News in the Life Sciences Industry

STOCKHOLM, Oct. 28, 2019 /PRNewswire/ -- Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation(®) with Accuray's Radixact® Treatment Delivery... Read more ››

STOCKHOLM, Oct. 25, 2019 /PRNewswire/ -- Oncoinvent announced today that research relating to a radioactivity standard for radium-224 (224Ra) in secular equilibrium has been published in the Journal of Applied Radiation and Isotopes by Oncoinvent research scientist Elisa Napoli and researchers... Read more ››

OSLO, Norway, Oct. 24, 2019 /PRNewswire/ -- Tone Kvåle, CFO, has today, 24 October 2019, purchased 5,000 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 19.96 per share. Following this transaction, Tone Kvåle holds 45,000 PSUs, 315,000 options and 191,275 shares... Read more ››

OSLO, Norway, Oct. 24, 2019 /PRNewswire/ -- Reference is made to the stock exchange announcement on 18 October 2019 where Nordic Nanovector ASA (OSE: NANO) (the "Company") announced the successful completion of a private placement raising gross proceeds of NOK 242,525,624 (the "Private Placement")... Read more ››

STOCKHOLM, Oct. 24, 2019 /PRNewswire/ -- "We are now regaining the exclusive, global rights to develop and commercialize ADC-1013 and at the same time receive enough ADC-1013 substance to, with or without a new partner, bring ADC-1013 into Phase II clinical trials next year. In total, we... Read more ››

Strong financials paving the way for broadening the business

GOTHENBURG, Sweden, Oct. 24, 2019 /PRNewswire/ -- Oblique Therapeutics AB announces that Sreesha P Srinivasa is on the list of invited speakers who will be presenting at the RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020.

LUND, Sweden, Oct. 23, 2019 /PRNewswire/ -- BioInvent International AB (publ) (OMXS: BINV) today announces it has concluded a production agreement with Cancer Research UK, the world's largest independent funder of cancer research, for the production of Hummingbird Bioscience's anti-HER3 antibody... Read more ››

TOREKOV, Sweden, Oct. 23, 2019 /PRNewswire/ --

LINKÖPING, Sweden, Oct. 23, 2019 /PRNewswire/ -- A new study published by authors from AMRA Medical, Linköping University and Pennington Biomedical Research Center in Journal of Gerontology: Medical Sciences on October 23, 2019 unveils a novel method for combined assessment of muscle... Read more ››

BANGKOK, Oct. 23, 2019 /PRNewswire/ -- Mundipharma was named one of the "Best Companies to Work for in Asia" in Thailand by HR Asia -- the premier publication on human resource professionals in the Asia Pacific. This is the first time Mundipharma Thailand has won the award in the country.

STOCKHOLM, Oct. 23, 2019 /PRNewswire/ -- On 31 October, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) will... Read more ››

STOCKHOLM, Oct. 22, 2019 /PRNewswire/ -- Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), today announced that the clinical trials, in the United States and Europe, for the company's first product ASTar® are expected to begin in the second half of 2020. This is a postponement as the trials... Read more ››